期刊文献+

肾上腺糖皮质激素在狼疮性肾炎治疗中的合理应用 被引量:5

The rational use of corticosteroids in the treatment of lupus nephritis
原文传递
导出
摘要 活动性系统性红斑狼疮及狼疮性肾炎常用肾上腺糖皮质激素联合免疫抑制剂作基础治疗,其中危重患者在此基础上还需加甲泼尼龙冲击强化治疗来迅速顿挫狼疮活动。本文拟对激素种类、常规治疗及冲击治疗方案、副反应及治疗目标做一详细讨论,以帮助临床医师合理用药。 Active systemic lupus erythematosus ( SLE ) and lupus nephritis ( LN ) are often treated with corticosteroids combined with various immunosuppressives. For the critical patients the methylprednisolone plus intensive therapy should be also used on the basis of above-mentioned routine treatment in order to abort the severe activity of SLE/LN rapidly. In this paper the sorts, the routine and intensive therapeutic regimens, the side-effects and the treatment targets of corticosteroids will be reviewed in detail.
作者 谌贻璞
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2009年第6期496-498,共3页 Chinese Journal of Practical Internal Medicine
关键词 系统性红斑狼疮 狼疮性肾炎 肾上腺糖皮质激素 systemic lupus erythematosus lupus nephritis corticosteroids
  • 相关文献

参考文献7

  • 1谌贻璞.肾病综合征[M]//杨晔.当代内科学,下册.北京:中国中医药出版社,2002:3101-3117.
  • 2系统性红斑狼疮诊治指南(草案)[J].中华风湿病学杂志,2003,7(8):508-513. 被引量:215
  • 3Appel GB,Radhakrishnan J,D'Agati V.Secondary glomerular disease[M]// Brenner BM.The Kidney,8th ed,Vol 1.Philadelphia:Saunders,2008:1067-1080.
  • 4West SG,Achenbach GA,Edelstein CL.Renal involvement in systemic lupus erythematesus[M]//Schrier RW.Diseases of the Kidhey and Urinary Tract,8th ed,Vol Ⅱ.Philadelphia:Lippincott Williams & wilkius,2007:1673-1699.
  • 5Appel GB,Cameron JS.Lupus Nephritis[M]//Feehally J,Floege J,Johnsen RJ,et al.Ompreheusive Clinical Nephrology,3rd ed.Philadelphia:Mosby,2007:291-303.
  • 6Balow JE,Waldman M,Austin Ⅲ HA.Lupus Nephritis[M]//Wilcox CS.Therapy in Nephrology & Hypertension.3rd ed.Philadelphia:Saunders,2008:157-171.
  • 7Weening JJ,D'Agati VD,Schwartz MM,et al.The classification of glomerulonephritis in systemic lupus erythematosus revisited[J].Kidney Int,2004,65(2):521 -530.

共引文献214

同被引文献75

  • 1初玉芹,楚海峰,钟英杰.环磷酰胺冲击疗法治疗狼疮性肾炎20例[J].吉林大学学报(医学版),2005,31(3):486-486. 被引量:3
  • 2李贤.狼疮性肾炎应用激素及免疫抑制剂后中医治疗[J].辽宁中医杂志,1995,22(10):453-453. 被引量:18
  • 3李波,宁宇,杨明堂,王志,杨平,刘娅.吸入糖皮质激素治疗儿童哮喘的有效性和安全性的Meta-分析[J].吉林大学学报(医学版),2006,32(5):883-887. 被引量:7
  • 4陈灏珠,主编.实用内科学[M]第12版.北京:人民卫生出版社,2005.1 231-1 245.
  • 5Baskin E,Ozen S,Cakar N,et al.The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis[J].Pediatr Nephrol,2010,25(1):111-117.
  • 6Frutos M A,Martin G A,Ramon E,et al.Intravenous cyclophosphamide in lupus nephritis:twenty years reducing dose[J].Nefrologia,2007,27(1):12-22.
  • 7Matsuyama N,Morimoto S,Tokano Y,et al.The long-term prognosis of lupus nephritis patients treated with intravenous cyclophosphamide[J].Intern Med,2010,49(9):823-828.
  • 8Houssiau F A,D′Cruz D,Sangle S,et al.Azathioprine versus mycophenolate mofetil for long-term immunosuppre-ssion in lupus nephritis:results from the MAINTAIN Nephritis Trial[J].Ann Rheum Dis,2010,69(12):2083-2089.
  • 9Wofsy D,Appel G B,Dooley M A,et al.Aspreva Lupus Management Study maintenance results[J].Lupus,2010,19(Suppl):27.
  • 10Roman M J,Shanker B A,Davis A,et al.Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus[J].N Engl J Med,2003,349(25):2399-406.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部